Foundayo (orforglipron) is a once‑daily glucagon‑like peptide‑1 (GLP‑1) receptor agonist. It’s approved for weight loss in people with obesity or overweight and have weight-related health conditions like high blood pressure, high cholesterol, type 2 diabetes, obstructive sleep apnea, or cardiovascular disease.
This medication is prescribed alongside a reduced-calorie diet and increased physical activity. Unlike oral semaglutide, which must be taken first thing in the morning on an empty stomach with no food, drink, or other medications for at least 30 minutes, Foundayo can be taken any time of day, with or without food or water.
What Is Foundayo (Orforglipron)
Foundayo is the brand name for orforglipron, a once-daily oral tablet approved by the FDA on April 1, 2026, for chronic weight management in adults. It is the first and only small-molecule (non-peptide) GLP-1 receptor agonist available.
Developed by Eli Lilly and Company, Foundayo belongs to the class of glucagon-like peptide-1 (GLP-1) receptor agonists. These medications mimic a natural gut hormone that helps regulate appetite, slow gastric emptying, and improve blood-sugar control.
Unlike injectable GLP-1 medications such as semaglutide or tirzepatide, and even the existing oral semaglutide tablet, Foundayo eliminates the need for needles, refrigeration, or strict morning fasting. It doesn’t have restrictions and can be taken at any time of day.
How Does Foundayo (Orforglipron) Work?
Foundayo (orforglipron) is a small-molecule, non-peptide oral GLP-1 receptor agonist. It mimics GLP-1, a hormone your body naturally produces after meals that regulates your appetite.
Foundayo works in several ways; first, it slows gastric emptying, so food stays in your stomach longer. As a result, you feel full faster and for longer. Second, it increases satiety by signaling the appetite centers in your brain that you’re full. This reduces hunger and cravings. Finally, it regulates blood sugar and appetite by prompting the pancreas to release insulin when blood sugar rises and by lowering glucagon, the hormone that raises blood sugar.
Foundayo (Orforglipron) Dosage
Foundayo (orforglipron) is taken as a single tablet once per day. Your provider will start you on the lowest dose and slowly increase it every 30 days (1 month). This gradual titration schedule is to help your body adjust and keep side effects as mild as possible.
Recommended dosing schedule
- Month 1: 0.8 mg by mouth once a day (Starting dose)
- Month 2: 2.5 mg by mouth once a day.
- Month 3: 5.5 mg by mouth once a day.
- Month 4 and beyond: After at least 30 days at each dose, your doctor may gradually increase your dosage to 9 mg, 14.5 mg, or 17.2 mg once daily if necessary. Your dosage will be determined by how well it works and whether you experience any negative effects.
You can take your Foundayo tablet at any time of day, morning, afternoon, or evening, with food or without food.
If you forget to take your Foundayo tablet, take it as soon as you remember. If it’s close to the time for your next dose, don’t take it, because this can raise your risk of side effects. Never take two tablets on the same day. Simply resume your normal once-daily schedule the following day.
Who Qualifies for Foundayo?
Foundayo (orforglipron) is FDA-approved for adults 18 years and older with obesity, defined as a body mass index (BMI) of 30 or higher, or who are overweight (BMI of 27 or higher) plus at least one weight-related medical condition, such as type 2 diabetes, high blood pressure, high cholesterol or triglycerides, obstructive sleep apnea, cardiovascular disease, or non-alcoholic fatty liver disease.
Who should NOT take Foundayo?
You should not use Foundayo if you have:
- A personal or family history of medullary thyroid carcinoma (MTC)
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- A history of pancreatitis
- Severe gastrointestinal disease (such as gastroparesis or inflammatory bowel disease)
- Known allergy or hypersensitivity to orforglipron or any of its ingredients
If you become pregnant, you should stop taking Foundayo since it may cause harm to a developing child. Additionally, it may reduce the effectiveness of birth control pills. Consult your care team if you use oral contraceptives. They may suggest switching to a non-oral method (such as an implant) or using a barrier method (such as condoms) for 30 days after beginning Foundayo and for 30 days following each dose increase.
Foundayo should also not be used by children or adolescents.
How Effective is Foundayo for Weight Loss?
Foundayo (orforglipron) delivers clinically meaningful weight loss when used together with a reduced-calorie diet and increased physical activity. In the pivotal ATTAIN-1 phase 3 clinical trial, adults with obesity or overweight who stayed on the highest dose lost an average of 12.4% of their body weight (about 27.3 pounds for someone starting at 220 pounds) after 72 weeks.
Even when including all participants regardless of whether they completed the full course, the average loss was still 11.1% (25 pounds) versus just 2.1% with the placebo.
Patients with type 2 diabetes in ATTAIN-2 saw an average weight loss of around 9.6–10.5% at the highest dose, along with meaningful improvements in blood sugar control.
Side Effects of Foundayo (Orforglipron)
Clinical studies show that Foundayo’s side effects are similar to those of injectable GLP-1 receptor agonists. Most side effects are mild to moderate, mostly gastrointestinal, and occur frequently during the early weeks of dose titration. They generally improve or disappear as your body adjusts.
Common side effects include:
- Nausea
- Constipation
- Diarrhea
- Vomiting
- Indigestion (dyspepsia)
- Abdominal pain
- Headache
- Fatigue
- Belching
- Heartburn
- Gas
- Air loss
Serious but rare Foundayo risks include:
- Pancreatitis (inflammation of the pancreas)
- Gallbladder problems (such as gallstones or cholecystitis)
- Acute kidney injury (usually related to dehydration from vomiting or diarrhea)
- Severe gastrointestinal reactions
- Hypoglycemia (low blood sugar), when combined with certain diabetes medications
Like all medications in this class, Foundayo carries a boxed warning for the potential risk of thyroid C-cell tumors, including medullary thyroid cancer, based on findings in rodent studies. It is not known whether this risk applies to humans, but Foundayo should not be used if you or your family have a history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Foundayo vs. Oral Semaglutide (Wegovy Pill): How Do They Compare?
Foundayo (orforglipron) and the Wegovy pill are both once-daily GLP-1 medications for weight loss that come as tablets taken by mouth. The difference is that the Wegovy pill must be taken first thing in the morning on an empty stomach, with no food, drink, or other medications for at least 30 minutes afterward. Foundayo does not have these strict rules; you can take it any time of day, without the hassle of food or water restrictions.
Unlike Foundayo, Wegovy is also available as a once-weekly subcutaneous injection and is approved for adults and certain adolescents. In addition, the injectable form of Wegovy carries extra FDA approvals for lowering the risk of heart attack, stroke, and cardiovascular death in adults with obesity or overweight and heart disease. Foundayo is not currently approved for these cardiovascular indications.
Both medications deliver clinically significant weight loss when combined with diet and exercise. However, the Wegovy pill appears to offer greater weight loss of around 13.6% compared to Foundayo (orforglipron), which showed an average weight loss of 12.4% at the highest dose.
Here’s a table showing a clear side-by-side comparison:
| Feature | Foundayo (orforglipron) | Wegovy pill |
| Dosing flexibility | Any time of day, with or without food | First thing in the morning on an empty stomach only; wait at least 30 minutes before eating, drinking, or taking other medications |
| Starting dose | 0.8 mg once daily | 1.5 mg once daily |
| maximum dose | 17.2 mg once daily | 25 mg once daily |
| Weight-loss results | Average 12.4% body weight reduction at higher dose | 13.6% weight loss at higher doses |
| Common side effects | GI-related (nausea, diarrhea, constipation); often milder after titration | Similar GI profile |
How to Get Foundayo
Foundayo is a prescription-only medication. To get it, you must have a doctor’s prescription first. Here’s how it works at NP2GO.
- Book your consultation: Schedule online in minutes or call our team on (405) 696-7003.
- Complete a thorough evaluation: During your secure video visit, your NP2GO provider reviews your full medical history, current medications, BMI, and weight-related conditions. We may order labs if needed and answer every question about Foundayo side effects, dosing, and what to expect.
- Receive a personalized prescription (if appropriate): If Foundayo is the right fit for you, your provider sends the prescription. We handle all the details so you don’t have to.
Choose convenient fulfillment: Fill at your local pharmacy, or use LillyDirect for direct-to-door shipping.
FAQs About Foundayo (Orforglipron)
Is Foundayo the same as Ozempic or Wegovy?
No, Foundayo (orforglipron) is not the same as Ozempic or Wegovy, though they are in the same class of medication. Foundayo is an oral GLP-1 medication that uses orforglipron, a small-molecule tablet taken once daily with no food restrictions. Ozempic and Wegovy contain semaglutide (available as an injection or oral pill) and have stricter dosing rules.
Can I take Foundayo with food or coffee?
Yes, you can take Foundayo with food or coffee. Unlike oral semaglutide (Rybelsus or the Wegovy pill), Foundayo has no food, water, or timing restrictions. You may take the once-daily tablet any time of day, morning, afternoon, or evening, with meals, coffee, or on an empty stomach.
How long does it take for Foundayo to work?
In clinical trials, most people using Foundayo daily started noticing results within 4 weeks. However, the greatest weight loss may take several months of treatment. Keep in mind that it takes time to gradually increase your dosage to help reduce your chance of side effects at the start of treatment. Additionally, since people are different, your results may appear sooner rather than later.
What are the most common side effects?
The most common side effects of Foundayo (orforglipron) are mild-to-moderate gastrointestinal issues that occur during the first few weeks of dose titration and improve over time. In clinical trials, these included nausea, constipation, diarrhea, and vomiting.
Is Foundayo safe during pregnancy or breastfeeding?
No, Foundayo is not recommended during pregnancy or while breastfeeding. Its effects on an unborn baby or infant have not been fully studied. Women of childbearing age should use effective contraception while taking it. If you are pregnant or planning to become pregnant, talk with your provider about safer weight-management options.
Can I switch from semaglutide to Foundayo?
Yes, you can safely switch from semaglutide to Foundayo (orforglipron) since both are GLP-1 medications. However, it’s important to do this with your healthcare provider’s help so they can create a smooth transition plan.
Ready to See if Foundayo Is Right for Your Weight-Loss Journey?
Foundayo (orforglipron) is an oral glucagon-like peptide-1 (GLP-1) receptor agonist. It’s approved for adults with obesity or overweight and have at least one weight-related medical problem, such as high blood pressure or high cholesterol.
This once-daily oral tablet is the first GLP-1 pill you can take any time of day, with or without food, and without the needles, refrigeration, or strict morning routines. Foundayo has shown clinically proven results of up to 12.4% body weight reduction when combined with healthy lifestyle changes.
If you’re ready to see if Foundayo is right for your weight-loss journey, book your virtual consultation with NP2GO today. We serve across 38 states, plus Washington, D.C., and in person at our Edmond, Oklahoma, clinic. Our team will review your health history, answer all your questions, and create a plan tailored to you, so you can move forward with confidence and convenience.